Home Newsletters Mammary Cell News Targeted Nanoparticle for Co-Delivery of HER2 siRNA and a Taxane to Mirror...

Targeted Nanoparticle for Co-Delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis

By
Justin.choi
-
0
A single therapeutic was developed based on trastuzumab-conjugated nanoparticles for co-delivering docetaxel and siRNA against HER2.
[Small]

Sorry, but the selected Zotpress account can't be found.

Abstract

RELATED ARTICLES

Exit mobile version